These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 34545713)

  • 1. Small molecule kinase inhibitors enhance aminolevulinic acid-mediated protoporphyrin IX fluorescence and PDT response in triple negative breast cancer cell lines.
    Palasuberniam P; Kraus D; Mansi M; Howley R; Braun A; Myers K; Chen B
    J Biomed Opt; 2021 Sep; 26(9):. PubMed ID: 34545713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of ABCG2 transporter by lapatinib enhances 5-aminolevulinic acid-mediated protoporphyrin IX fluorescence and photodynamic therapy response in human glioma cell lines.
    Mansi M; Howley R; Chandratre S; Chen B
    Biochem Pharmacol; 2022 Jun; 200():115031. PubMed ID: 35390338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of aminolevulinic acid-mediated protoporphyrin IX fluorescence and enhancement by ABCG2 inhibitors in renal cell carcinoma cells.
    Howley R; Mansi M; Shinde J; Restrepo J; Chen B
    J Photochem Photobiol B; 2020 Oct; 211():112017. PubMed ID: 32919173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting ABCG2 transporter to enhance 5-aminolevulinic acid for tumor visualization and photodynamic therapy.
    Chandratre S; Olsen J; Howley R; Chen B
    Biochem Pharmacol; 2023 Nov; 217():115851. PubMed ID: 37858868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of lapatinib for enhancing 5-aminolevulinic acid-mediated protoporphyrin IX fluorescence and photodynamic therapy in human cancer cell lines with varied ABCG2 activities.
    Howley R; Olsen J; Chen B
    Photochem Photobiol; 2024 Mar; ():. PubMed ID: 38477138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methods to Measure the Inhibition of ABCG2 Transporter and Ferrochelatase Activity to Enhance Aminolevulinic Acid-Protoporphyrin IX Fluorescence-Guided Tumor Detection and Resection.
    Mansi M; Howley R; Chen B
    Methods Mol Biol; 2022; 2394():823-835. PubMed ID: 35094360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ABCG2 transporter inhibitor restores the sensitivity of triple negative breast cancer cells to aminolevulinic acid-mediated photodynamic therapy.
    Palasuberniam P; Yang X; Kraus D; Jones P; Myers KA; Chen B
    Sci Rep; 2015 Aug; 5():13298. PubMed ID: 26282350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement of the efficacy of 5-aminolevulinic acid-mediated photodynamic treatment in human oral squamous cell carcinoma HSC-4.
    Yamamoto M; Fujita H; Katase N; Inoue K; Nagatsuka H; Utsumi K; Sasaki J; Ohuchi H
    Acta Med Okayama; 2013; 67(3):153-64. PubMed ID: 23804138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accumulation of protoporphyrin IX in medulloblastoma cell lines and sensitivity to subsequent photodynamic treatment.
    Briel-Pump A; Beez T; Ebbert L; Remke M; Weinhold S; Sabel MC; Sorg RV
    J Photochem Photobiol B; 2018 Dec; 189():298-305. PubMed ID: 30445362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Silencing Heme Biosynthesis Enzymes on 5-Aminolevulinic Acid-mediated Protoporphyrin IX Fluorescence and Photodynamic Therapy.
    Yang X; Li W; Palasuberniam P; Myers KA; Wang C; Chen B
    Photochem Photobiol; 2015; 91(4):923-30. PubMed ID: 25809721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The inhibition of ferrochelatase enhances 5-aminolevulinic acid-based photodynamic action for prostate cancer.
    Fukuhara H; Inoue K; Kurabayashi A; Furihata M; Fujita H; Utsumi K; Sasaki J; Shuin T
    Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):399-409. PubMed ID: 24284092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel potential photodynamic therapy strategy using 5-Aminolevulinic acid for ovarian clear-cell carcinoma.
    Teshigawara T; Mizuno M; Ishii T; Kitajima Y; Utsumi F; Sakata J; Kajiyama H; Shibata K; Ishizuka M; Kikkawa F
    Photodiagnosis Photodyn Ther; 2018 Mar; 21():121-127. PubMed ID: 29196245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Her2 oncogene transformation enhances 5-aminolevulinic acid-mediated protoporphyrin IX production and photodynamic therapy response.
    Yang X; Palasuberniam P; Myers KA; Wang C; Chen B
    Oncotarget; 2016 Sep; 7(36):57798-57810. PubMed ID: 27527860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mangostin enhances efficacy of aminolevulinic acid-photodynamic therapy against cancer through inhibition of ABCG2 activity.
    Lai HW; Tani Y; Sukatta U; Rugthaworn P; Thepyos A; Yamamoto S; Fukuhara H; Inoue K; Yuasa H; Nakamura H; Ogura SI
    Photodiagnosis Photodyn Ther; 2023 Dec; 44():103798. PubMed ID: 37696317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ferrochelatase Deficiency Abrogated the Enhancement of Aminolevulinic Acid-mediated Protoporphyrin IX by Iron Chelator Deferoxamine.
    Palasuberniam P; Kraus D; Mansi M; Braun A; Howley R; Myers KA; Chen B
    Photochem Photobiol; 2019 Jul; 95(4):1052-1059. PubMed ID: 30767226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptide-targeted dendrimeric prodrugs of 5-aminolevulinic acid: A novel approach towards enhanced accumulation of protoporphyrin IX for photodynamic therapy.
    Tewari KM; Dondi R; Yaghini E; Pourzand C; MacRobert AJ; Eggleston IM
    Bioorg Chem; 2021 Apr; 109():104667. PubMed ID: 33611140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental investigation of a combinational iron chelating protoporphyrin IX prodrug for fluorescence detection and photodynamic therapy.
    Magnussen A; Reburn C; Perry A; Wood M; Curnow A
    Lasers Med Sci; 2022 Mar; 37(2):1155-1166. PubMed ID: 34218351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of protoporphyrin IX synthesis to photodynamic effects by 5-aminolaevulinic acid and its esters on various cell lines derived from the skin.
    Lee JB; Choi JY; Chun JS; Yun SJ; Lee SC; Oh J; Park HR
    Br J Dermatol; 2008 Jul; 159(1):61-7. PubMed ID: 18489589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of Renal Cell Carcinoma Cell Response to the Enhancement of 5-aminolevulinic Acid-mediated Protoporphyrin IX Fluorescence by Iron Chelator Deferoxamine
    Howley R; Mansi M; Shinde J; Restrepo J; Chen B
    Photochem Photobiol; 2023 Mar; 99(2):787-792. PubMed ID: 35857390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of therapeutic efficacy of 5-aminolevulinic acid-based photodynamic therapy in human prostate cancer.
    Yamamoto S; Fukuhara H; Seki H; Kawada C; Nakayama T; Karashima T; Ogura SI; Inoue K
    Photodiagnosis Photodyn Ther; 2021 Sep; 35():102452. PubMed ID: 34303032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.